Worldwide Generic Prescription Drug Industry

Title	Published	Price
Mapping the Healthcare Landscape Bringing pharmaceuticals into focus By: Datamonitor Introduction Courtesy of the patent cliff, the pharmaceutical industry is set for a dramatic slow down in revenue growth from 2011. Industry players are therefore looking to implement strategies which will cushion them against the \| more...	11/12/2009	$7,600.00
Generic Pharmaceuticals Industry Report By: Plimsoll Publishing Ltd. The Global Generic Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth \| more...	11/1/2009	$1,500.00
Asia Pacific Pharma Sector Analysis By: RNCOS The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region \| more...	11/1/2009	$1,200.00
Antipsychotics Market Forecast By: Datamonitor Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is \| more...	10/28/2009	$15,200.00
Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion By: Datamonitor Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is \| more...	10/28/2009	$15,200.00
Generics: Global Industry Guide By: Datamonitor Datamonitor's Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive \| more... Search inside this report	10/14/2009	$1,495.00
Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential By: Datamonitor Introduction In 2008, seven major market sales of anticonvulsants reached $13.6 billion, making it one of the largest therapeutic drug classes in the Pharmaceutical sector. However, generic incursion of second generation anticonvulsants will continue to increase \| more...	10/8/2009	$15,200.00
Partnering in the Global Generics Industry 2008: A Guide to Companies By: Espicom Healthcare Intelligence Partnering is increasingly the choice for securing market share and business growth... ... Teva’s recent acquisition of Barr Pharmaceuticals may be the latest headline grabbing deal, but industry and commerce alike must have a complete \| more... Search inside this report	10/6/2009	$1,130.00
Cardiovascular Outlook: Pharmaceutical, Medical Device, New Technologies - Past, Present, and Future By: Canon Communications, LLC Cardiovascular disease is the leading cause of death in the United States, affecting an estimated 80.7 million American adults, with estimated treatment costs of more than $313.8 billion annually. This report contains qualitative analysis of \| more...	10/1/2009	$535.00
China Hospital Drug Utilization Volume Executive Summary 2nd Edition 2009 By: Draco Healthcare Consulting LLC The total Chinese pharmaceutical market had reached RMB 828.36 billion (US$ 120.84 billion, at an exchange rate of US $1 = RMB 6.83) with an annual growth rate (AGR) of 26.50% in 2008. The growth \| more...	10/1/2009	$4,400.00

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 4